Wet Cupping in Non-specific Low Back Pain

Safety and Efficacy of Wet Cupping on Persistent Non-specific Low Back Pain: A Randomized, Controlled, Open-label, Parallel-group

Background: Persistent nonspecific low back pain (PNSLBP) is one of the most common low back pains worldwide. Many interventions were tried including wet cupping which is commonly used for pain conditions in Saudi Arabia and other parts in the world but without solid scientific evidence.

Aims: This study aims at determining safety and efficacy of wet cupping for treating PNSLBP.

Methods: This is a randomized wait-listed controlled clinical trial. Eligible patients with history of at least 3 months of PNSLBP will be randomized in to two groups, 45 patients each. The first group will be given wet-cupping treatment at two acupuncture points of urinary Bladder (BL) meridians among the BL23, BL24 and BL25, 6 times within 2 weeks. The second group will serve as a control group. Usual care, including providing brochures for exercise, general advice for PNSLBP and acetaminophen, will be allowed in both groups. Separate assessors participated in the outcome assessment. Investigators will use the 0 to100 numerical rating scale (NRS) for pain, the McGill Pain questionnaire for pain intensity (PPI) and the Oswestry Disability Questionnaire (ODQ), and to assess acetaminophen use and safety issues.

Expected Results: To provide data on the safety and effectiveness of wet cupping in treating PNSLBP and open the way for integrative medicine in Saudi Arabia

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Objectives:

To evaluate the effectiveness of wet cupping in the treatment of NSLBP:

  1. Primary objective: To assess the effect of wet cupping on Pain (difference in the NRS from base to the end of two weeks) compared to the control group
  2. Secondary objectives :

I-To compare Functioning (Oswestry Disability Questionnaire) from the base to the end of the two weeks of wet cupping sessions& two weeks later in the two groups II-To compare NRS from base to two weeks after the end of cupping III-To compare Number of Acetaminophen tables taken at the end of two weeks. IV-To evaluate Safety of wet cupping

SPECIFIC HYPOTHESIS: The hypothesis of this study is that the improvement of Numeric Rating Scale (NRS) for Pain at the end of the study will be greater in the Wet Cupping Treatment group than in the Control group

Overall Design: a randomised, waiting-list controlled, open-label, parallel trial.

  • Study Type: Interventional
  • Condition: Persistent Non Specific Low Back Pain (PNSLBP)

Case definition parameters:

  • Low back pain: is defined as pain and discomfort, localized , below the costal margin and above the inferior gluteal folds, with or without referred leg pain.,
  • Persistent low back pain: is defined as low back pain persisting for at least 12 weeks. We do not deal specifically with repeated, short bouts of pain.
  • Nonspecific low back pain: is defined as" low back pain that is not attributable to a recognizable, known specific pathology (e.g. infection, tumour, osteoporosis, fracture, structural deformity, inflammatory disorder (e.g. ankylosing spondylitis), radicular syndrome or caudal equine syndrome)."

Study Design:

Study Type

Interventional

Enrollment (Actual)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Jeddah, Saudi Arabia
        • King Fahad Specialist Hospital
      • Madinah, Saudi Arabia
        • King Fahad Hospital
      • Riyadh, Saudi Arabia
        • Prince Salman Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. - Patients who have had non-specific low back pains at least 12 weeks now.
  2. - Interested in using wet cupping therapy
  3. - Age equal or more than 18 years up to 60 years of age.

Exclusion Criteria:

  • 1-Patients who have low back pain due to specific and known etiological causes (infection, tumor, osteoporosis, ankylosing spondylitis, fracture, inflammatory process, radicular syndrome, cauda equinal syndrome).

    2-Patients who are inappropriate to the wet cupping treatment.

    • ◦AIDS, Active Hepatitis, Tuberculosis, Syphilis. (N.B.)Referring physicians will be advised to exclude patients with the above mentioned diseases.
    • ◦Patients who regularly take anticoagulants, antiplatelet drugs
    • ◦Anemia, thrombocytopenia
    • ◦Hemorrhagic disease like hemophilia
    • ◦Diabetes
    • ◦Severe cardiovascular disease
    • ◦Kidney diseases (renal failure, chronic renal disease)

      3-Patients who have experiences of wet cupping treatment during last 3 months. 4-Patients who have had treatment for low back pain during last 2 weeks. 5-Patients who are in pregnancy or have plan to conception. 6-Patients who have vertebra surgery or have plan of surgery.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: wet cupping
patient will receive wet cupping
Participants assigned to the treatment group will receive wet-cupping therapy 3 times per week for 2 weeks
Other Names:
  • Hijamah
No Intervention: control
not cupping

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
NRS
Time Frame: at the end of the two weeks wet cupping sessions.
Difference in Numeric Rating Score at the base and at the end of two weeks of cupping sessions.
at the end of the two weeks wet cupping sessions.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Scores of the McGill Pain questionnaire for pain intensity (PPI)
Time Frame: at the end of two weeks of cupping sessions and two weeks later
Change in the score from base line
at the end of two weeks of cupping sessions and two weeks later
the Oswestry Disability Questionnaire (ODQ),
Time Frame: at the end of two weeks of cupping sessions and two weeks later
change in the score from the base line
at the end of two weeks of cupping sessions and two weeks later
Number of Participants with Serious and Non-Serious Adverse Events
Time Frame: at the last visit, one week after the end of the last sessions
Differences in number of participants with Serious and Non-Serious Adverse Events.
at the last visit, one week after the end of the last sessions

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Abdullah M AlBedah, MD, National Center for Complementary and Integrative Health (NCCIH)
  • Study Director: Mohamed K.M. Khalil, MD, National Center for Complementary and Integrative Health (NCCIH)

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2014

Primary Completion (Actual)

November 1, 2014

Study Completion (Actual)

January 1, 2015

Study Registration Dates

First Submitted

December 3, 2013

First Submitted That Met QC Criteria

December 10, 2013

First Posted (Estimate)

December 16, 2013

Study Record Updates

Last Update Posted (Estimate)

April 1, 2015

Last Update Submitted That Met QC Criteria

March 31, 2015

Last Verified

March 1, 2015

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • MOH044

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Persistent Non Specific Low Back Pain

Clinical Trials on wet cupping

3
Subscribe